# Perlara — Perlara: building the YC for rare disease parents

```yaml
url: "https://forg.to/companies/perlara"
website: "http://perlara.com"
industry: "Healthtech"
company_size: "1-10 employees"
headquarters: "San Francisco, USA"
is_hiring: false
open_roles: 0
verified: false
created: 2026-07-23
```

## About Perlara

Perlara 1.0 (Feb 2014 - Feb 2019) launched early R&D joint ventures called PerlQuests with highly motivated rare disease families, companies or impact investors. We screened gene-edited patient avatars for repurposable drugs in order to build a predictive R&D engine called ArkBase. We planned to monetize programs based on ArkBase predictions by selectively spinning out asset-centric clinical development NewCos. Perlara 1.5 (March 2019 - April 2020) was the transition to a one-person virtual clinical development company and when the epalrestat and aripiprazole repurposing trials were launched at Mayo Clinic for the treatment of PMM2-CDG and NGLY1-CDDG, respectively. Perlara 2.0 (May 2020 --> The first decentralized and distributed biotech

## Links

- Website: http://perlara.com
- Forg: https://forg.to/companies/perlara

---
Listed on [Forg](https://forg.to) — the professional network for builders

_HTML version: https://forg.to/companies/perlara_